COR · NYSE · CIK 0001140859
Cencora, Inc.
Cencora, Inc.’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 21, 2026. In fiscal 2025 (year ended Sep 30, 2025) it reported revenue of $321.3B and net income of $1.6B, according to its XBRL data on EDGAR. Its EDGAR record lists 68 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Cencora, Inc.
- Ticker
- COR
- SEC Central Index Key (CIK)
- 0001140859
- Industry (SIC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (code 5122)
- Business address
- CONSHOHOCKEN, PA
- State or country of incorporation
- DE
- Fiscal year ends
- September 30
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #261 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Cencora, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Sep 30, 2021 | FY2022 ended Sep 30, 2022 | FY2023 ended Sep 30, 2023 | FY2024 ended Sep 30, 2024 | FY2025 ended Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $214.0B | $238.6B | $262.2B | $294.0B | $321.3B |
| Net income | $1.5B | $1.7B | $1.7B | $1.5B | $1.6B |
| Diluted EPS | $7.39 | $8.04 | $8.53 | $7.53 | $7.96 |
| Total assets | $57.3B | $56.6B | $62.6B | $67.1B | $76.6B |
| Cash and equivalents | $2.5B | $3.4B | $2.6B | $3.1B | $4.4B |
XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Nov 25, 2025 | 10-K | Annual report· period Sep 30, 2025 | Document · Index |
| Aug 5, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Oct 21, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Oct 21, 2026 | Document · Index |
| Jan 22, 2026 | DEF 14A | Definitive proxy statement· period Mar 5, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about Cencora, Inc., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 21, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Oct 21, 2026 | Document · Index |
| Oct 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026 | Document · Index |
| Oct 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026 | Document · Index |
| Oct 1, 2026 | 3 | Initial statement of beneficial ownership· period Oct 1, 2026 | Document · Index |
| Sep 25, 2026 | 8-K | Director or officer change; Regulation FD disclosure· period Sep 24, 2026 | Document · Index |
| Sep 17, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 16, 2026 | Document · Index |
| Sep 16, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Sep 11, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Sep 4, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Sep 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 1, 2026 | Document · Index |
| Sep 1, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 24, 2026 | Document · Index |
| Aug 24, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 14, 2026 | 8-K | Director or officer change· period Aug 13, 2026 | Document · Index |
| Aug 12, 2026 | 8-K | Regulation FD disclosure· period Aug 12, 2026 | Document · Index |
| Aug 6, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 5, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 5, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Aug 5, 2026 | Document · Index |
| Aug 5, 2026 | 8-K | Material agreement; New financial obligation· period Jul 31, 2026 | Document · Index |
| Aug 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026 | Document · Index |
| Aug 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026 | Document · Index |
| Aug 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026 | Document · Index |
| Jul 7, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jul 7, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jun 30, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 29, 2026 | Document · Index |
| Jun 30, 2026 | 3 | Initial statement of beneficial ownership· period Jun 29, 2026 | Document · Index |
| Jun 24, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 22, 2026 | Document · Index |
| Jun 22, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026 | Document · Index |
| Jun 18, 2026 | 11-K | Annual report of employee stock plans· period Dec 31, 2025 | Document · Index |
| Jun 15, 2026 | 8-K | Director or officer change; Regulation FD disclosure· period Jun 10, 2026 | Document · Index |
| May 29, 2026 | SD | Specialized disclosure report (conflict minerals) | Document · Index |
| May 29, 2026 | 8-K | Director or officer change; Regulation FD disclosure· period May 23, 2026 | Document · Index |
| May 28, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 28, 2026 | Document · Index |
| May 6, 2026 | 10-Q | Quarterly report· period Mar 31, 2026 | Document · Index |
| May 6, 2026 | 8-K | Results of operations; Regulation FD disclosure· period May 6, 2026 | Document · Index |
| May 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 1, 2026 | Document · Index |
| May 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 1, 2026 | Document · Index |
| May 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 1, 2026 | Document · Index |
| Apr 29, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Apr 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026 | Document · Index |
Insider filing activity
68 Form 4 filings appear in Cencora, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Wholesale-Drugs, Proprietaries & Druggists' Sundries
All 4 companies in Wholesale-Drugs, Proprietaries & Druggists' Sundries· Companies headquartered in Pennsylvania
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001140859 and XBRL company facts. Cencora, Inc. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement